InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Rowland Lloyd A, Conseiller Général. Insider active across 1 company, notably CytomX Therapeutics, Inc.. Cumulatively, 11 disclosures have been logged. Breakdown: 0 buy · 4 sells. Total volume traded: €25k. History available since 2 February 2022. The latest transaction was disclosed on 18 March 2025 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Rowland Lloyd A
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations11 total
10,203 shares@ US$0.59922.7% of flowCommon StockSEC:0001610717-25-000083:0
11,250 shares0Common StockSEC:0001610717-24-000434:0
5,268 shares@ US$2.085541.0% of flowCommon StockSEC:0001610717-24-000179:0
25,000 shares0Common StockSEC:0001610717-24-000035:0
4,077 shares@ US$1.380720.8% of flowCommon StockSEC:0001610717-23-000420:0
11,250 shares0Common StockSEC:0001610717-23-000409:0
15,000 shares0Common StockSEC:0001610717-23-000296:0
2,037 shares@ US$1.97915.5% of flowCommon StockSEC:0001140361-23-012616:0
25,000 shares0Common StockSEC:0001567619-23-001928:0
15,000 shares0Common StockSEC:0001567619-22-014298:0
22,500 shares0Common StockSEC:0001567619-22-002524:0
11 of 11 declarations
About Rowland Lloyd A
ROWLAND LLOYD A is General Counsel at CytomX Therapeutics, Inc. In this role, he oversees the company's legal and regulatory affairs, ensuring compliance with applicable laws. His expertise in business law is crucial for risk management and protecting CytomX's interests. ROWLAND plays a key role in the company's legal strategy.
